Summit Financial, LLC Abb Vie Inc. Transaction History

Summit Financial, LLC

$2.54 Billion
Q3 2024

A detailed history of Summit Financial, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Summit Financial, LLC holds 40,081 shares of ABBV stock, worth $7.02 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares

40,081

Previous 38,511 4.08%

Holding current value

$7.02 Million

Previous $6.61 Million 19.83%

% of portfolio

0.31%

Previous 0.3%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$163.84 - $199.33 $257,228 - $312,948	1,570 Added 4.08%	40,081 $7.92 Million
Q2 2024 Jul 31, 2024	BUY	$154.79 - $180.76 $2.46 Million - $2.88 Million	15,912 Added 70.41%	38,511 $6.61 Million
Q1 2024 Apr 24, 2024	BUY	$159.82 - $182.1 $1.08 Million - $1.23 Million	6,764 Added 42.72%	22,599 $4.12 Million
Q4 2023 Feb 05, 2024	SELL	$137.6 - $154.97 $1.96 Million - $2.21 Million	-14,247 Reduced 47.36%	15,835 $2.45 Million
Q3 2023 Nov 07, 2023	BUY	$133.59 - $154.65 $584,589 - $676,748	4,376 Added 17.02%	30,082 $4.48 Million
Q2 2023 Aug 11, 2023	BUY	$132.51 - $164.9 $2.15 Million - $2.68 Million	16,261 Added 172.17%	25,706 $3.46 Million
Q1 2023 May 03, 2023	BUY	$144.61 - $166.54 $67,388 - $77,607	466 Added 5.19%	9,445 $1.51 Million
Q4 2022 Feb 07, 2023	BUY	$138.31 - $165.87 $686,709 - $823,544	4,965 Added 123.69%	8,979 $1.45 Million
Q3 2022 Nov 15, 2022	BUY	$134.21 - $153.93 $183,465 - $210,422	1,367 Added 51.64%	4,014 $539 Million
Q2 2022 Aug 12, 2022	SELL	$137.62 - $174.96 $30,689 - $39,016	-223 Reduced 7.77%	2,647 $405,000
Q1 2022 May 10, 2022	BUY	$131.98 - $163.75 $44,477 - $55,183	337 Added 13.3%	2,870 $465,000
Q4 2021 Feb 07, 2022	BUY	$107.43 - $135.93 $272,120 - $344,310	2,533 New	2,533 $342,000

Others Institutions Holding ABBV

# of Institutions

3,855

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit Financial, LLC with notifications on news.

Account

Summit Financial, LLC Abb Vie Inc. Transaction History